Clinical Trials Directory

Trials / Completed

CompletedNCT04019860

Time-restricted Eating and High Intensity Interval Training Among Women

Isolated and Combined Effects of High Intensity Interval Training and Time Restricted Eating on Glycaemic Control in Reproductive-aged Women With Overweight or Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This project will determine the independent and combined effects of high intensity interval training and time-restricted eating on blood sugar regulation among women in reproductive-age who have overweight or obesity. The intervention period will be seven weeks. Before and after the intervention, blood sugar regulation, body composition and physical fitness will be measured and compared between groups who are doing either high intensity interval training, time-restricted eating, both high intensity interval training and time-restricted eating, or who are in a control group. Physical activity, sleep quality, continuous glucose monitoring, adherence to the interventions and hunger/satiety will also be measured.

Detailed description

In a follow-up study, we will invite randomized participants to come in for new assessments of physical fitness, body composition and fasting blood samples, and they will be asked to complete questionnaires about adherence to the interventions two years after intervention-end. The first participants will come in to the laboratory for the two-year follow up in November 2021.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh Intensity Interval TrainingThree weekly, supervised exercise sessions with high intensity. Each session will last for 30-45 minutes. Intervention period will be seven weeks.
BEHAVIORALTime-Restricted EatingRestricted daily window of caloric intake to maximum 10 hours. Intervention period will be seven weeks.

Timeline

Start date
2019-08-12
Primary completion
2021-03-16
Completion
2021-03-16
First posted
2019-07-15
Last updated
2021-09-20

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04019860. Inclusion in this directory is not an endorsement.